Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
550 participants
INTERVENTIONAL
2006-03-31
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
NCT02812212
Functional MRI Evaluation in Pyeloureteral Junction Syndrome in Children
NCT05498532
Change of Urinary Metabolic Profile Secondary to a Congenital Urine Flow Impairment (UFI) by Nuclear Magnetic Resonance (NMR) and Metabolomics Analysis
NCT02792348
Ultrasonography Sensibilized by Oral Hydration and Hydronephrosis in Children.
NCT02086760
Applicability of Uroflowmetry in Children with Cerebral Palsy
NCT05017415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objectives of the study are:
* to evaluate the feasibility and reliability of the measurement of the relative renal function by MR urography compared to renal scintigraphy in the management of patients presenting with chronic and intermittent urinary obstruction in adults and children.
* if the accuracy of the two methods is demonstrated as equivalent, to conduct a medico-economic evaluation of functional MR Urography compared to renal scintigraphy, and show potential lower costs.
The secondary objectives are:
* to compare the diagnostic accuracy of various parameters of analysis of functional MR urography data, previously published in the literature, and determine indicators for predicting urinary obstruction
* to evaluate the interest of these indicators after surgical treatment of obstruction, or during the follow-up of patients
* to draw up a program of analysis and treatment of MR urography data, available for all centres whatever their MR unit.
The current study has a multicentric, observational, prospective design for the evaluation of a diagnostic strategy. It includes 16 French hospitals.
The main clinical hypothesis is that during one single MR examination, by the association of a morphological diagnostic phase and a functional phase, it will be possible to extract functional parameters having the same accuracy that renal scintigraphy in the determination of relative renal function.
The targeted recruitment is of 550 patients for two years. The MR and scintigraphy collected data will be reviewed in one site by experts at the end of the study. The university hospital of Nancy is in charge of coordinating the study.
Points of expected impact of the study are:
1. a shortening of the duration of patients management by replacing two examinations (MR and scintigraphy) by one single examination (MR )
2. a reduction of delivered exposure to diagnostic radiation, by eliminating renal scintigraphy in the initial diagnostic and follow-up of children an adults.
3. potential applications in improving the spatial resolution of MR urography after correction of artefacts such as respiratory motion.
4. the publication of clinical recommendations by the National Scientific Societies supporting the trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MR urography
undergoing both renal scintigraphy and MR within a month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
undergoing both renal scintigraphy and MR within a month
Exclusion Criteria
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Direction de la Recherche et de l'Innovation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel CLAUDON, PhD
Role: PRINCIPAL_INVESTIGATOR
Service de Radiologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Angers
Angers, , France
Chu Bordeaux
Bordeaux, , France
Chru Lille
Lille, , France
Ap-Hm Marseille
Marseille, , France
Fondation LENVAL
Nice, , France
AP-HP Trousseau
Paris, , France
AP-HP Saint Vincent de Paul
Paris, , France
AP-HP Robert Debré
Paris, , France
AP-HP Bicêtre
Paris, , France
Chu Poitiers
Poitiers, , France
Chu Reims
Reims, , France
Chu Rennes
Rennes, , France
Chu Rouen
Rouen, , France
Chu Strasbourg
Strasbourg, , France
Chu Tours
Tours, , France
CHU NANCY Hôpital Brabois enfant
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI 2005 - 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.